Northwestern study finds California life expectancy yet to recover since COVID-19
The study, published in the Journal of the American Medical Association, found that overdoses and cardiovascular diseases were the leading causes of life expectancy loss in California.
COVID-19 also remained a contributing factor.
Hannes Schwandt, Northwestern professor and lead researcher of the study, and his team analyzed California data because it is comprehensive and typically published ahead of the Centers for Disease Control and Prevention's national data. The researchers used California's Comprehensive Death Files and obtained population counts for calculating mortality rates from the American Community Survey.
"California is the biggest state [by population], so it gives us an idea of trends," he said.
Life expectancy is the estimated lifespan of a human based on prevailing age specific mortality rates, according to Northwestern University.
"2020 was bad, 2021 was even worse, and then we didn't see a rebound, or even overshooting in life expectancy the next year. We saw continued deficit in life expectancy compared to 2019," Schwandt said.
Schwandt compared it to the 1918 influenza pandemic, in which multiple studies show that life expectancy in the United States rebounded after one to two years, unlike COVID-19, which continues to impact life expectancy over five years later.
The study found that Californians' life expectancy dropped nearly a year from 81.4 to 80.5 by 2024.
While the life expectancy gap between income groups returned to pre-pandemic levels by 2024 after widening during 2020–2023, disparities between racial groups grew even larger.
In 2024, Black people lived on average six and a half years less than white people in California.
Black Californians experienced a slower but more prolonged decline in life expectancy: losing four years by 2021 due to COVID deaths, but the gap further widened due to fentanyl overdoses.
Hispanic Californians had the most severe single-year life expectancy drop of five years in 2021 due to COVID-19. Still, overdoses and cardiovascular disease continue to reduce their life expectancy by more than a year.
Overdoses impacted poor communities the hardest, while cardiovascular disease was the primary cause for the drop in life expectancy for wealthier and white people.
"The fentanyl crisis particularly took off in 2020 and continues to be a problem," Schwandt said.
Other research studies show a strong correlation between the COVID-19 pandemic and the fentanyl epidemic.
A study published in the National Library of Medicine calls the pandemic an "important epoch in the opioid epidemic timeline." Societal disruptions, economic stress, and limited access to treatment increased the risk of overdoses, according to the study.
Schwandt also said that overprescribing opioids is a part of the larger problem.
In 2024, 87% of opioid overdose deaths in Cook County involved fentanyl. African Americans make up 53% of those total overdose deaths.
A Penn State study found that by the start of the pandemic, a Black person over the age of 55 in Illinois, Wisconsin, and Minnesota was 5 times more likely to die of a drug overdose than a white person of the same age.
"The good news is that in 2024, overdose deaths did decline for the first time," Scwandt said. "But because they increase so dramatically over the years, we are still in a territory that is unacceptable."
Provisional data from the CDC found a nearly 24% decline in US drug overdose deaths.
Schwandt said that increased deaths from cardiovascular disease could be potentially linked to obesity and Long COVID.
"I think that's a really interesting hypothesis that we should explore more," he said.
"Maybe in richer areas, people have more access to COVID treatment and survive, have a higher burden of Long COVID, which then could lead to higher cardiovascular mortality," Schwandt said.
Long COVID is an all-encompassing name for the long-term symptoms and health effects a person can experience after contracting COVID-19, regardless of the severity of the case. Long COVID is a disorder that can impact almost all parts of the body, including the heart, brain, immune system, and gastrointestinal system.
A 2024 study published in the European Journal of Preventive Cardiology found that "undeniably, the Long COVID syndrome has a multifaceted interplay with the cardiovascular system."
The researchers looked at 78 different studies to compile different cardiovascular manifestations of Long COVID and found that cardiac symptoms are the third most common clinical manifestation of the disease.
Schwandt examines trends in life expectancy and compares the data in the U.S. to that of other developed countries to see how the U.S. can increase its life expectancy.
"Countries like Spain, that have lower incomes, and less technology, and they're healthier and live longer [than the US]," he said.
He looks at different causes, areas, and incomes throughout the U.S. and other developed countries to determine who is living the longest and why.
Schwandt wants to expand the study once the U.S. numbers are available to researchers.
"I'd like to analyze the data in rich and poor populations in other developed countries and compare them to the U.S. experience," he said. "How is the world recovering, and is there anything we can learn from that?"
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
14 minutes ago
- Fox News
Forget 10,000 steps — research reveals the real number you need for better health
You may not need as many steps as you thought. Ten thousand steps per day has been widely recommended as the standard benchmark for physical activity — but a new study suggests that just 7,000 could be enough to boost essential health markers. Researchers from the University of Sydney conducted a review of 57 studies spanning more than 10 countries, which tracked participants' steps and health outcomes. SIMPLE JAPANESE FITNESS TREND COULD ADD 7 YEARS TO LIFE EXPECTANCY, EXPERTS SAY Led by Professor Melody Ding from the School of Public Health, the team looked at how different daily step counts impacted the risk of dying from heart disease and cancer, as well as the risk of developing cancer, type 2 diabetes, dementia and depression, according to a university press release. They found that walking at least 7,000 steps a day was linked to improvement in eight major health outcomes, including heart disease, dementia and depressive symptoms. "Any increase in daily steps, even modest ones like 4,000 steps, delivers health benefits compared to very low activity levels," Ding told Fox News Digital. "When possible, targeting around 7,000 steps per day can substantially reduce risks for many chronic diseases and adverse health outcomes." "Even small increases in step counts, such as increasing from 2,000 to 4,000 steps a day, are associated with significant health gain." Higher step counts beyond 7,000 may add extra benefits, but the improvement rate slows, she noted. The results were published in The Lancet Public Health journal. In particular, the researchers found that walking 7,000 steps a day reduced the risk of death by 47%, almost exactly the same as 10,000 steps. That same step benchmark was also linked to a 38% reduced risk of dementia and a 22% reduced risk of type 2 diabetes, both only slightly lower than the benefit of 10,000 steps, the release stated. "Significant health improvements" were reported when people increased from 2,000 steps per day to anywhere between 5,000 and 7,000. "Aiming for 7,000 steps is a realistic goal based on our findings, which assessed health outcomes in a range of areas that hadn't been looked at before," said Professor Ding in the release. "However, for those who cannot yet achieve 7,000 steps a day, even small increases in step counts, such as increasing from 2,000 to 4,000 steps a day, are associated with significant health gain." For those who are already very active and consistently hitting 10,000+ steps, Ding said, "keep it up — there's no need to cut back." The researchers also noted that stepping doesn't need to happen all at once or require intentional exercise. "Everyday movements count — like getting off the bus a stop earlier or choosing stairs over elevators," Ding advised. "Small, incidental bouts throughout the day add up and contribute to health. Embrace opportunities to move more in practical, enjoyable ways." There were some limitations in the study, the researchers noted. "For some outcomes, we have a small number of studies," Ding told Fox News Digital. There are also some study-level biases, she said. "For example, people who are already unwell will take fewer steps because of their health conditions," Ding said. "And while there is an indication that the dose-response may be different for older adults, we didn't have enough data for all outcomes to explore it." It's also important to note that while walking offers great health benefits, it is not a complete "package" in itself, she noted. "Everyday movements count — like getting off the bus a stop earlier or choosing stairs over elevators." "Try to also incorporate strength training and mobility exercise into a weekly routine for more complete health benefits." In next steps, the researchers plan to use these findings to shape future physical activity guidelines. For more Health articles, visit Experts recommend that future studies of step count impacts should focus on variations for age, health status and region, the release stated. "Our research helps to shift the focus from perfection to progress," Ding said. "Even small increases in daily movement can lead to meaningful health improvements."
Wall Street Journal
14 minutes ago
- Wall Street Journal
Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag
Meet Vinay Prasad, a young disciple of Bernie Sanders who ranks as one of the most powerful officials in the federal government. He determines whether patients get access to many life-saving medicines. Or not. Think of him as a one-man death panel. Dr. Prasad was named by Marty Makary, the Food and Drug Administration commissioner, as head of the agency's biologics division in May, and last month as its chief medical and scientific officer. More on why he was tapped to these posts later. But it isn't an exaggeration to say that Dr. Prasad wields more power than Anthony Fauci ever did at the National Institutes of Health.
Yahoo
18 minutes ago
- Yahoo
Brains Aged Faster In 2021–2022: What Did The Pandemic Do To Us?
A new study suggests that the pandemic may have had a significant impact on our brains, whether or not we contracted COVID-19. Leveraging an extensive database of brain scans, British researchers say that people's brains showed accelerated aging during 2021 and 2022, including signs of shrinkage. While people who were infected with COVID also showed cognitive decline, like slower processing speed, the study was notable because it said even the non-infected were likely to experience harm to their brain. While the study did not delve into the exact causes of the accelerated aging, the study's first author, Ali-Reza Mohammadi-Nejad, a neuroimaging researcher at the University of Nottingham, theorizes that it may have been the result of stress and other factors. 'But it is likely that the cumulative experience of the pandemic—including psychological stress, social isolation, disruptions in daily life, reduced activity and wellness—contributed to the observed changes… In this sense, the pandemic period itself appears to have left a mark on our brains, even in the absence of infection,' said Mohammadi-Nejad, per NBC. The researchers found that males and 'those from more socioeconomically deprived backgrounds' experienced the most significant brain aging. Overall, the pandemic was thought to be linked to a 5.5-month acceleration in the aging process. This is not the first time researchers have reached similar conclusions. Last year, a previous study found that teenagers experienced dramatic brain aging during the pandemic. Notably, the study suggested that girls' brains aged 4.2 years faster and boys' brains aged 1.3 years faster, on average. The latest study does not indicate whether the structural changes identified in individuals who have never contracted COVID will result in any noticeable changes in brain function. Nor does the study confirm whether the physical changes will persist over the long term, says Adam Brickman, a professor of neuropsychology at Columbia University Vagelos College of Physicians and Surgeons, who was not involved in the study.
